America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...

CVS Health shares fell Friday as the pharmacy and healthcare company announced an immediate change at CEO, with company ...

Longtime executive David Joyner, 60, took over on Thursday after CVS repeatedly missed earnings targets, setting off unrest ...

The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.

U.S. equities were mixed at midday with the tech sector getting a big boost from Netflix, which reported strong quarterly ...

CVS has replaced CEO Karen Lynch with longtime pharmacy benefits executive David Joyner. The company has been struggling to ...

To arrest that rise, and boost sales and profits at its retail pharmacy division, CVS said Friday that it has replaced CEO ...

CVS stock is lower Friday after the embattled healthcare company said Karen Lynch is out as CEO, effective immediately.

As the new CEO at CVS, Joyner’s strategic partner will be CFO Tom Cowhey, who was promoted to the role in January after ...

On Thursday, CVS Health Corp (CVS) stock saw a decline, ending the day at $63.67 which represents a decrease of $-1.35 or -2.08% from the prior close of $65.02. The stock opened at $63.41 and touched ...

The general mood among these heavyweight investors is divided, with 58% leaning bullish and 41% bearish. Among these notable ...

Vest Financial LLC bought a new stake in CVS Health Co. (NYSE:CVS – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange ...